149 related articles for article (PubMed ID: 20048556)
1. [Androgen replacement therapy improves health-related quality of life in late onset hypogonadism patients].
Taniguchi H; Kawa G; Kinoshita H; Matsuda T
Hinyokika Kiyo; 2009 Dec; 55(12):741-4. PubMed ID: 20048556
[TBL] [Abstract][Full Text] [Related]
2. Symptomatic change in Japanese hypogonadal patients several years after androgen replacement therapy.
Taniguchi H; Kawa G; Kinoshita H; Matsuda T
Aging Male; 2011 Sep; 14(3):190-4. PubMed ID: 21557686
[TBL] [Abstract][Full Text] [Related]
3. Change in cytokine levels after administration of saikokaryuukotsuboreito or testosterone in patients with symptoms of late-onset hypogonadism.
Tsujimura A; Miyagawa Y; Okuda H; Yamamoto K; Fukuhara S; Nakayama J; Takao T; Nonomura N; Okuyama A
Aging Male; 2011 Mar; 14(1):76-81. PubMed ID: 20712429
[TBL] [Abstract][Full Text] [Related]
4. Is discontinuation of hormone replacement therapy possible for patients with late-onset hypogonadism?
Tsujimura A; Takada S; Matsuoka Y; Hirai T; Takao T; Miyagawa Y; Nonomura N; Okuyama A
Int J Urol; 2008 Jul; 15(7):625-9. PubMed ID: 18479356
[TBL] [Abstract][Full Text] [Related]
5. [Role of androgen in the elderly. Clinical androgen replacement therapy for late-onset hypogonadism].
Amano T
Clin Calcium; 2013 Aug; 23(8):1179-84. PubMed ID: 23892219
[TBL] [Abstract][Full Text] [Related]
6. Prostate-specific antigen changes and prostate cancer in hypogonadal men treated with testosterone replacement therapy.
Coward RM; Simhan J; Carson CC
BJU Int; 2009 May; 103(9):1179-83. PubMed ID: 19154450
[TBL] [Abstract][Full Text] [Related]
7. [The efficacy of testosterone ointment (Glowmin) treatment for late-onset-hypogonadism (LOH) patients according to LOH severity].
Amano T; Imao T; Takemae K; Iwamoto T; Baba K; Yamakawa K; Nakazawa R; Yoshida K; Sugimori H; Tanaka T; Katabami T; Tanaka M
Hinyokika Kiyo; 2007 Jan; 53(1):25-9; discussion 29. PubMed ID: 17310765
[TBL] [Abstract][Full Text] [Related]
8. Clinical impact of tamsulosin on generic and symptom-specific quality of life for benign prostatic hyperplasia patients: using international prostate symptom score and Rand Medical Outcomes Study 36-item Health Survey.
Suzuki H; Yano M; Awa Y; Nakatsu H; Egoshi K; Mikami K; Ota S; Okano T; Hamano S; Ohki T; Furuya Y; Ichikawa T
Int J Urol; 2006 Sep; 13(9):1202-6. PubMed ID: 16984553
[TBL] [Abstract][Full Text] [Related]
9. Intermittent androgen replacement for intense hypogonadism symptoms in castrated patients.
Ferreira U; Leitao VA; Denardi F; Matheus WE; Stopiglia RM; Netto NR
Prostate Cancer Prostatic Dis; 2006; 9(1):39-41. PubMed ID: 16276352
[TBL] [Abstract][Full Text] [Related]
10. Double-blind placebo-controlled study of testosterone patch therapy on bone turnover in men with borderline hypogonadism.
Merza Z; Blumsohn A; Mah PM; Meads DM; McKenna SP; Wylie K; Eastell R; Wu F; Ross RJ
Int J Androl; 2006 Jun; 29(3):381-91. PubMed ID: 16390499
[TBL] [Abstract][Full Text] [Related]
11. [Analysis of the statues of patients visiting our specialized clinic for hypogonadal men: 5-year experience].
Kawa G; Taniguchi H; Kinoshita H; Matsuda T
Hinyokika Kiyo; 2009 Feb; 55(2):87-92. PubMed ID: 19301613
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of changing testosterone gel preparations (Androgel or Testim) among suboptimally responsive hypogonadal men.
Grober ED; Khera M; Soni SD; Espinoza MG; Lipshultz LI
Int J Impot Res; 2008; 20(2):213-7. PubMed ID: 17898800
[TBL] [Abstract][Full Text] [Related]
13. Prospective assessment of health-related quality of life in men with late-onset hypogonadism who received testosterone replacement therapy.
Sumii K; Miyake H; Enatsu N; Matsushita K; Fujisawa M
Andrologia; 2016 Mar; 48(2):198-202. PubMed ID: 25988884
[TBL] [Abstract][Full Text] [Related]
14. Androgen replacement therapy improves psychological distress and health-related quality of life in late onset hypogonadism patients in Chinese population.
Zhang XW; Liu ZH; Hu XW; Yuan YQ; Bai WJ; Wang XF; Shen H; Zhao YP
Chin Med J (Engl); 2012 Nov; 125(21):3806-10. PubMed ID: 23106878
[TBL] [Abstract][Full Text] [Related]
15. Androgen replacement therapy contributes to improving lower urinary tract symptoms in patients with hypogonadism and benign prostate hypertrophy: a randomised controlled study.
Shigehara K; Sugimoto K; Konaka H; Iijima M; Fukushima M; Maeda Y; Mizokami A; Koh E; Origasa H; Iwamoto T; Namiki M
Aging Male; 2011 Mar; 14(1):53-8. PubMed ID: 21171937
[TBL] [Abstract][Full Text] [Related]
16. Bone mineral density in hypogonadal men remains low after long-term testosterone replacement.
Ishizaka K; Suzuki M; Kageyama Y; Kihara K; Yoshida K
Asian J Androl; 2002 Jun; 4(2):117-21. PubMed ID: 12085102
[TBL] [Abstract][Full Text] [Related]
17. [Evaluation of health-related quality of life in dialysis patients. Personal experience using questionnaire SF-36].
Kusztal M; Nowak K; Magott-Procelewska M; Weyde W; Penar J
Pol Merkur Lekarski; 2003 Feb; 14(80):113-7. PubMed ID: 12728668
[TBL] [Abstract][Full Text] [Related]
18. Oral testosterone undecanoate (Andriol) supplement therapy improves the quality of life for men with testosterone deficiency.
Park NC; Yan BQ; Chung JM; Lee KM
Aging Male; 2003 Jun; 6(2):86-93. PubMed ID: 12898792
[TBL] [Abstract][Full Text] [Related]
19. Androgens and cognitive function.
Cherrier MM
J Endocrinol Invest; 2005; 28(3 Suppl):65-75. PubMed ID: 16044582
[TBL] [Abstract][Full Text] [Related]
20. Testosterone therapy in men with Parkinson disease: results of the TEST-PD Study.
Okun MS; Fernandez HH; Rodriguez RL; Romrell J; Suelter M; Munson S; Louis ED; Mulligan T; Foster PS; Shenal BV; Armaghani SJ; Jacobson C; Wu S; Crucian G
Arch Neurol; 2006 May; 63(5):729-35. PubMed ID: 16682542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]